Serving healthcare companies
for more than a decade

 IBC is a boutique top-management consulting firm located in northern Germany,
providing tailored-solutions to clients around the globe

Experienced Team

We are experienced consultants and industry experts - e.g. pharmacists, medical doctors, pharma/med-tech executives - with fundamental cross-functional consulting know-how.

Industry specialization

We are specialized in helping healthcare and life-science companies as well as service providers / investors  from around the globe to solve their high-impact challenges in this industry.

Collaborative spirit

We work closely and collaboratively with our client team - from concept to implementation -  to develop tailored solutions,  identify potential resistance for change and achieve lasting results.

Sound advise to drive change

We believe in analytical and conceptual strength at the core. With pragmatism and experience this leads to increased performance. Our objective is to drive change, not create reports.

Yven Zacharias

Managing Director

As Managing Director, Yven ensures all projects meet clients expectations.  Yven is an expercienced Top-Management consultant,  with deep insights across the healthcare and life-science domain.  He holds a masters degree in Business Administration from HEC Paris and multiple Executive Education courses from Harvard Business School and INSEAD.  Prior to joining IBC, he worked for a BCG spin-off, specialzing in healthcare, which was acquired by Bain in 2018.

Consulting services

Strategy

We develop, validate and help our clients implement effective corporate, business and functional strategies

Operation

We identify, quantify and support the execution of operational improvements that translate directly to productivity gains

Organization

We help clients design organizations in line with their strategy to reduce costs, drive growth, and strengthen performance 

Compliance

We drive and support major compliance efforts from Pre-Approval Inspections to Warning-Letter Remediation for all regulatory authorities

Industry focus

Selected previous client engagements

  • Organizational design focused on Medical Device and Combination Product units for global pharmaceutical company
  • Strategy development for parenteral Medical Device and Combination Products 
  • Increase robustness for multi-billion Dollar pharmaceutical product
  • Regulatory compliance for ~50 biologics and biosimilars
  • Inspection preparation “FDA-Readiness” for multiple Health Authorities
  • Turnaround management (quality and technical area) after „Warning Letter“
  • Improve resource utilization and oversight in development QA
  • Project Management Office for large transitions 
  • Etc.

Selected previous client engagements

  • Reorganize leading German regional statutory health insurer 
  • Reorganize medical aids sector for a leading German SHI
  • Reorganize the headquarter of a leading German SHI  
  • Optimize economic efficiency of drug management for a German SHI  
  • Improve economic efficiency in the hospital invoice verification process, travel cost and medical aids and recourses for multiple German SHIs
  • Optimize Managed Care, particular for high cost intensive care patients in home care for a German SHI
  • Project Management Office for the reorganization of a leading regional SHI in southern Germany 
  • Etc.


Selected previous client engagements

  • Develop growth strategies for various private and university hospital cardiovascular centers 
  • Increase productivity for multiple cardiovascular centers  
  • Strategic realignment for a leading provider of managed services and online services to pharmacies, ranging from drug information systems to inventory management systems
  • Establish reviews as part of divestment processes („Commercial Due Diligence“) for Private Equity investors with focus on growth and return on investment potential quantification based mid-term market potential
  • Etc.

Selected previous client engagements

  • Develop global process organization for a global supplier in the extracorporeal blood treatment division
  • Determine future business strategy of Healthcare DACH for a global diversified technology company     
  • Etc.

Share by: